U.S.–East Africa program to prevent, detect early, and link people with HIV-related cancers to care
Official title: United States-East Africa HIV-Associated Malignancy Research Center (USEAHAMRC) for Career Development and the Prevention, Early Detection and Efficient Linkage to Care for Virus-related Cancers
Funded at University of California, San Francisco · NIH-11410161 · Data updated 2026-11-12
This program brings U.S. and East African teams together to help people with HIV by improving prevention, earlier detection, and faster connection to care for cancers linked to the virus.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | July 13, 2020 |
| Project end | June 30, 2026 |
| Funding year | 2025 |
| Award (this year) | $23,375 |
| NIH project number | 3U54CA254571-06S2 |
| Project ID | NIH-11410161 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are people living with HIV in the East African regions served by the partner clinics, including women at risk for cervical cancer and people at risk for Kaposi’s sarcoma who may be offered screening or prevention services.
✕Less likely to help
People without HIV or those living outside the participating East African catchment areas are unlikely to be directly helped by this program.
What this research studies
This program brings U.S. and East African teams together to improve prevention and early detection of cancers linked to HIV, especially cervical cancer and Kaposi’s sarcoma. It builds a collaborative network of hospitals and researchers across the regions to run coordinated projects and share best practices. The center funds career development so emerging African investigators can lead local research and build sustainable services. Participating clinics will pilot improved screening, diagnostic methods, and systems to make sure people found to have cancer are quickly connected to treatment.
Why it matters
Potential benefit: If successful, this work could lead to more screening, earlier cancer diagnosis, and quicker access to treatment for people with HIV in East Africa.
How similar studies have gone: Screening and linkage programs have improved cancer outcomes in other settings, but combining regional capacity building with focused HIV-related cancer prevention and early detection in East Africa is a relatively new and less-tested approach.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Martin, Jeffrey N — University of California, San Francisco
- Study coordinator: Martin, Jeffrey N
Related research
Other NIH-funded projects on the same topics.
-
Detecting cancer risk and treatment response in NF1 nerve tumors using cfDNA markers
A doctor-led study will test blood-based DNA markers to detect when NF1-related nerve tumors become malignant and to monitor how well treatment is working.
-
Epigenetic Basis for Controlling Aggressive IDH-Mutant Gliomas
Aims to understand and shape the epigenetic changes in IDH-mutant brain tumors to restrain their growth, which could lead to new, targeted treatment options for patients.
-
US–East Africa center to prevent and detect virus-linked cancers in people with HIV
This program builds a US–East Africa research network to train local investigators and improve prevention, earlier detection, and faster connection to care for virus-related cancers in people with HIV.
-
U.S.–East Africa center to prevent and find HIV-related cancers and speed connection to care
This program builds a U.S.–East Africa team to improve prevention, earlier detection, and faster linkage to care for people with HIV at risk for cervical cancer and Kaposi’s sarcoma.
-
Boosting TET Activity to Help Treat AML with Vitamin C
Vitamin C may help people with a type of blood cancer (AML) by boosting a natural anti-cancer pathway, potentially improving outcomes for adults with this disease.
-
Tissue tension and cancer: how stiff tissues drive cancer growth and spread
This NIH grant explores how stiff tissue environments and mechanical forces inside the body may promote cancer growth, aggression, and spread, with the goal of finding biomarkers and new drug targets that could help patients.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.